Lanean...
Optimizing T-cell receptor gene therapy for hematologic malignancies
Recent advances in genetic engineering have enabled the delivery of clinical trials using patient T cells redirected to recognize tumor-associated antigens. The most dramatic results have been seen with T cells engineered to express a chimeric antigen receptor (CAR) specific for CD19, a differentiat...
Gorde:
| Argitaratua izan da: | Blood |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5316910/ https://ncbi.nlm.nih.gov/pubmed/27207802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-11-629071 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|